{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:53:58Z","timestamp":1789912438600,"version":"4.0.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NCI","award":["T32CA101642"],"award-info":[{"award-number":["T32CA101642"]}]},{"DOI":"10.13039\/100007313","name":"MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["2P50CA098258-06"],"award-info":[{"award-number":["2P50CA098258-06"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ygyno.2018.10.034","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T05:08:43Z","timestamp":1541653723000},"page":"31-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Prognostic factors impacting survival in early stage uterine carcinosarcoma"],"prefix":"10.1016","volume":"152","author":[{"given":"Katherine C.","family":"Kurnit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Previs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela T.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon N.","family":"Westin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann H.","family":"Klopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan M.","family":"Fellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen H.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois M.","family":"Ramondetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1785-4072","authenticated-orcid":false,"given":"Nicole D.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2018.10.034_bb0005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2009.06.011","article-title":"Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review","volume":"115","author":"Boruta","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2018.10.034_bb0010","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ygyno.2012.09.012","article-title":"Uterine papillary serous cancer: a review of the literature","volume":"127","author":"del Carmen","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2018.10.034_bb0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ygyno.2005.04.027","article-title":"Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer","volume":"98","author":"Amant","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2018.10.034_bb0020","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ygyno.2009.02.003","article-title":"Management of women with clear cell endometrial cancer: a Society of Gynecologic Oncology (SGO) review","volume":"113","author":"Olawaiye","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2018.10.034_bb0025","first-page":"1368","article-title":"Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component","volume":"24","author":"de Jong","year":"2011","journal-title":"Mod. Pathol. Off. J. U. S. Can. Acad. Pathol. Inc."},{"issue":"1","key":"10.1016\/j.ygyno.2018.10.034_bb0030","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/AOG.0b013e318176157c","article-title":"Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior","volume":"112","author":"Bansal","year":"2008","journal-title":"Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.ygyno.2018.10.034_bb0035","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/PAS.0b013e3181161ba3","article-title":"Prognostic features of surgical stage I uterine carcinosarcoma","volume":"31","author":"Ferguson","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"issue":"6","key":"10.1016\/j.ygyno.2018.10.034_bb0040","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/IGC.0000000000000720","article-title":"Uterine sarcoma: analysis of 13,089 cases based on surveillance, epidemiology, and end results database","volume":"26","author":"Hosh","year":"2016","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"issue":"3","key":"10.1016\/j.ygyno.2018.10.034_bb0045","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0360-3016(03)01561-X","article-title":"Malignant mixed Mullerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome","volume":"58","author":"Callister","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.ygyno.2018.10.034_bb0050","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ygyno.2009.10.053","article-title":"The impact of multi-modal therapy on survival for uterine carcinosarcomas","volume":"116","author":"Gonzalez Bosquet","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.10.034_bb0055","author":"Network NCC"},{"issue":"2","key":"10.1016\/j.ygyno.2018.10.034_bb0060","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"issue":"1","key":"10.1016\/j.ygyno.2018.10.034_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004347-199001000-00001","article-title":"Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases","volume":"9","author":"Silverberg","year":"1990","journal-title":"Int. J. Gynecol. Pathol. Off. J. Int. Soc. Gynecol. Pathol."},{"issue":"4 Suppl","key":"10.1016\/j.ygyno.2018.10.034_bb0070","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/cncr.2820710440","article-title":"Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study","volume":"71","author":"Major","year":"1993","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2018.10.034_bb0075","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<512::AID-CNCR13>3.0.CO;2-4","article-title":"Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients","volume":"82","author":"Iwasa","year":"1998","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2018.10.034_bb0080","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ygyno.2015.09.002","article-title":"A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma","volume":"139","author":"Dickson","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2018.10.034_bb0085","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ygyno.2004.11.022","article-title":"Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study","volume":"96","author":"Sutton","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2018.10.034_bb0090","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1200\/JCO.2006.06.4907","article-title":"Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group study","volume":"25","author":"Homesley","year":"2007","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818313179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818313179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T15:24:03Z","timestamp":1662391443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825818313179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0090825818313179"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.10.034","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors impacting survival in early stage uterine carcinosarcoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.10.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}